Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-040289
Filing Date
2025-03-17
Accepted
2025-03-17 16:16:33
Documents
123
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K agen-20241231.htm   iXBRL 10-K 4718020
2 EX-4.14 agen-ex4_14.htm EX-4.14 46588
3 EX-19.1 agen-ex19_1.htm EX-19.1 122819
4 EX-21.1 agen-ex21_1.htm EX-21.1 4977
5 EX-23.1 agen-ex23_1.htm EX-23.1 4107
6 EX-31.1 agen-ex31_1.htm EX-31.1 16654
7 EX-31.2 agen-ex31_2.htm EX-31.2 16878
8 EX-32.1 agen-ex32_1.htm EX-32.1 11390
9 GRAPHIC img190554621_0.jpg GRAPHIC 265099
  Complete submission text file 0000950170-25-040289.txt   19344535

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20241231.xsd EX-101.SCH 2464137
126 EXTRACTED XBRL INSTANCE DOCUMENT agen-20241231_htm.xml XML 3489665
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 25744660
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)